• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物制剂中药物稳定性的分析方面。

Analytical aspects of the stabilization of drugs in pharmaceutical formulations.

作者信息

Raether G

机构信息

Ernst-Moritz-Arndt University, Greifswald, BRD.

出版信息

Acta Pharm Hung. 1991 Sep;61(5):231-8.

PMID:1785352
Abstract

The selection of a suitable procedure for stabilizing a drug in various pharmaceutical formulations requires highly specific and accurate analytical methods. In this paper the general problems associated with the specificity of the selected analytical methods (spectrophotometry, HPLC etc.) are discussed through the examples of phenyl-alkylamine and phenothiazine drugs. Studying the influence of different antioxidants on the rate of decomposition and detecting simultaneously the decomposition products, radicals and intact active ingredients enabled a better understanding of the degradation mechanism. The impurity profile (different decomposition products in the mixture) was found to be the function of the type and concentration of the stabilizers. A kinetic study demonstrated on phenylalkylamine type drugs using selective analytical methods clarified the mechanism of stabilizer action and allowed the perfect description of the degradation pathway.

摘要

为在各种药物制剂中稳定药物而选择合适的方法需要高度特异且准确的分析方法。本文通过苯烷基胺类和吩噻嗪类药物的例子,讨论了与所选分析方法(分光光度法、高效液相色谱法等)特异性相关的一般问题。研究不同抗氧化剂对分解速率的影响,并同时检测分解产物、自由基和完整的活性成分,有助于更好地理解降解机制。发现杂质谱(混合物中不同的分解产物)是稳定剂类型和浓度的函数。使用选择性分析方法对苯烷基胺类药物进行的动力学研究阐明了稳定剂的作用机制,并能完美描述降解途径。

相似文献

1
Analytical aspects of the stabilization of drugs in pharmaceutical formulations.药物制剂中药物稳定性的分析方面。
Acta Pharm Hung. 1991 Sep;61(5):231-8.
2
Stabilization of dithranol in topical formulations.局部用制剂中蒽林的稳定性。
Acta Pharm Hung. 1998 Nov;68(6):313-21.
3
Impurity profile tracking for active pharmaceutical ingredients: case reports.活性药物成分的杂质概况追踪:病例报告
J Pharm Biomed Anal. 2007 Jun 28;44(2):421-9. doi: 10.1016/j.jpba.2006.11.004. Epub 2006 Dec 4.
4
[Efficacy testing of stabilizing agents in epinephrine model solutions. 19: Stability of drugs and preparations].[肾上腺素模型溶液中稳定剂的效能测试。19:药物与制剂的稳定性]
Pharmazie. 1983 Jan;38(1):37-42.
5
Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC.采用稳定性指示高效液相色谱法测定原料药和药物制剂中的甲磺酸奈非那韦。
J Pharm Biomed Anal. 2006 Jun 7;41(3):1065-9. doi: 10.1016/j.jpba.2006.02.003. Epub 2006 Mar 20.
6
Recommended methods for the evaluation of drugs prepared by the Joint Committee of the Pharmaceutical Society and the Society for Analytical Chemistry on methods for the evaluation of drugs: the assay of phenothiazine.药学会与分析化学学会联合委员会推荐的药物评价方法:吩噻嗪的含量测定。
Analyst. 1969 Oct;94(123):932-41.
7
[Light transmittance and light-protective action of containers for phenylalkylamine solutions. 84: Contributions to problems concerning the use of plastic containers for liquid pharmaceutical preparations; 18: Stability of drugs and preparations].[苯烷基胺溶液容器的透光率和光防护作用。84:关于液体药物制剂使用塑料容器相关问题的探讨;18:药物与制剂的稳定性]
Pharmazie. 1983 Jan;38(1):30-3.
8
Oxidative degradation of phenothiazines. II. Quantitative determination of phenothiazine and some degradation products.吩噻嗪的氧化降解。II. 吩噻嗪及一些降解产物的定量测定。
Pharm Acta Helv. 1975;50(3):64-5.
9
The separation of EPO from other proteins in medical products formulated with different stabilizers.
Acta Pol Pharm. 2005 May-Jun;62(3):177-82.
10
HPLC analysis of S-adenosyl-L-methionine in pharmaceutical formulations.药物制剂中S-腺苷-L-蛋氨酸的高效液相色谱分析
Pharmazie. 2001 Aug;56(8):626-8.